BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25444467)

  • 1. Imaging approach to hepatocellular carcinoma, cholangiocarcinoma, and metastatic colorectal cancer.
    Fowler KJ; Saad NE; Linehan D
    Surg Oncol Clin N Am; 2015 Jan; 24(1):19-40. PubMed ID: 25444467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablative technologies for hepatocellular, cholangiocarcinoma, and metastatic colorectal cancer of the liver.
    Hansen PD; Cassera MA; Wolf RF
    Surg Oncol Clin N Am; 2015 Jan; 24(1):97-119. PubMed ID: 25444471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
    Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
    J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular cancer, cholangiocarcinoma, and metastatic tumors of the liver.
    Wagman LD
    Surg Oncol Clin N Am; 2015 Jan; 24(1):xiii-xiv. PubMed ID: 25444478
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatocellular cancer, cholangiocarcinoma, and metastatic tumors of the liver.
    Petrelli NJ
    Surg Oncol Clin N Am; 2015 Jan; 24(1):xi-xii. PubMed ID: 25444477
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathology of combined hepatocellular-cholangiocarcinoma.
    Yeh MM
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1485-92. PubMed ID: 20796144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liver resection (part I) -- anatomical basis, indication, and preoperative planning].
    Oldhafer KJ; Bourquain H; Stavrou GA
    Zentralbl Chir; 2006 Apr; 131(2):W22-33; W34-5. PubMed ID: 16612771
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
    Lee JH; Chung GE; Yu SJ; Hwang SY; Kim JS; Kim HY; Yoon JH; Lee HS; Yi NJ; Suh KS; Lee KU; Jang JJ; Kim YJ
    J Clin Gastroenterol; 2011 Jan; 45(1):69-75. PubMed ID: 20142755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?
    Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF
    Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones".
    Hunt JP; Varnholt H
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepato-cholangiocarcinoma with diffuse metastases and hypercalcemia].
    Pérez Roldán F; Carretero L; Aguirre A; Bañares R; Casado M; Cos E; Clemente G
    Rev Esp Enferm Dig; 1995 Oct; 87(10):743-7. PubMed ID: 8519543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma.
    Watanabe M; Akagi S; Hamamoto S
    Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582
    [No Abstract]   [Full Text] [Related]  

  • 14. Colorectal liver metastasis with intrabiliary growth: case report and review of the literature.
    Coppola S; Zucchini N; Romano F; Bovo G; Gilardoni E; Nespoli L; Gianotti L
    Int J Surg Pathol; 2014 May; 22(3):272-9. PubMed ID: 23775020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic bile duct dilatation due to liver metastases from colorectal carcinoma.
    Jhaveri KS; Halankar J; Aguirre D; Haider M; Lockwood G; Guindi M; Fischer S
    AJR Am J Roentgenol; 2009 Sep; 193(3):752-6. PubMed ID: 19696289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
    Shetty AS; Fowler KJ; Brunt EM; Agarwal S; Narra VR; Menias CO
    Abdom Imaging; 2014 Apr; 39(2):310-22. PubMed ID: 24407728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
    Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y
    Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of nonalcoholic fatty liver disease and liver cancer.
    Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
    World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of combined hepatocellular-cholangiocarcinoma with sarcomatous transformation and second primary colon cancer].
    Kim JH; Lee YG; Lee J; Jung CK; Kim HT; Kang H; Kho KH; Hong SP; Hwang SG; Park PW; Rim GS
    Korean J Hepatol; 2004 Jun; 10(2):142-7. PubMed ID: 15218348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of hepatocellular-cholangiocarcinoma invading the gallbladder].
    Namkoong KY; Kang MJ; Im HM; Kim MS; Ko BS; Ahn HT; Lee JR; Kim JO
    Korean J Hepatol; 2004 Jun; 10(2):148-53. PubMed ID: 15218349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.